Alnylam Pharmaceuticals, Inc. (ALNY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alnylam Pharmaceuticals, Inc. (ALNY)

ALNY 434.61

-4.7%

9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: RadMan55 who wrote (101)	1/10/2007 10:45:59 AM
From: tuck	of 166

Thanks to Nigel for pointing out what my sleepy eyes missed, that being the royalties . . . usually low single digits for deals of this type. Delivery is the chief bug-bear of RNAi therapeutics, so I do hope Inex' technology helps, for the sake of patients and investors alike. Anyhow, Bulba points out that Inex rose 77% on the deal yesterday, so . . . Congratulations! Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next